Open Access

Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration - an animal study

  • Authors:
    • Marine E. Baset
    • Tasneem I. Ali
    • Hanan Elshamy
    • Ahmed M. El Sadek
    • Diana G. Sami
    • Marwa T. Badawy
    • Sara S. Abou-Zekry
    • Hana H. Heiba
    • Mona K. Saadeldin
    • Ahmed Abdellatif
  • View Affiliations

  • Published online on: May 12, 2020     https://doi.org/10.3892/ijfn.2020.2
  • Article Number: 2
  • Copyright: © Baset et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Herbal medicine is used by millions of diabetic patients due to economic and cultural factors. The current study investigates the antidiabetic potential of fenugreek (Trigonella foenum-graecum) seed extract at a dose of 100 mg/kg in a Streptozocin-induced diabetic model. Male Sprague-Dawley rats received either intraperitoneal fenugreek [daily (ED) or every other day (EOD)] or oral fenugreek supplement daily, for four weeks. Results show that fenugreek significantly reduced blood glucose. Urea levels were reduced after daily intraperitoneal injection, and creatinine levels dropped after oral treatment, respectively. AST and ALT levels were reduced following fenugreek treatment, while protein levels significantly increased. High-density lipoprotein (HDL) increased after daily injections, while triglycerides decreased significantly in all groups. Glutathione S-transferase and catalase increased with treatment, while peroxidase antioxidant enzyme levels were reduced. Glutathione peroxidase levels increased only after daily injection. Histologically, fenugreek mildly protected hepatic, renal, and pancreatic tissues. In conclusion, the current study shows some potential benefits of fenugreek use. Oral and injectable fenugreek showed improvement in blood glucose, renal and liver functions. Although triglyceride levels decreased significantly, no significant changes in cholesterol levels were seen after fenugreek use. Higher doses and longer fenugreek treatment duration are recommended for the optimum protection of the liver, kidneys, and pancreatic tissues.
View Figures
View References

Related Articles

Journal Cover

January 2021
Volume 1 Issue 1

Print ISSN: -
Online ISSN:2634-7237

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Baset ME, Ali TI, Elshamy H, El Sadek AM, Sami DG, Badawy MT, Abou-Zekry SS, Heiba HH, Saadeldin MK, Abdellatif A, Abdellatif A, et al: Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration - an animal study. Int J Funct Nutr 1: 2, 2021
APA
Baset, M.E., Ali, T.I., Elshamy, H., El Sadek, A.M., Sami, D.G., Badawy, M.T. ... Abdellatif, A. (2021). Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration - an animal study. International Journal of Functional Nutrition, 1, 2. https://doi.org/10.3892/ijfn.2020.2
MLA
Baset, M. E., Ali, T. I., Elshamy, H., El Sadek, A. M., Sami, D. G., Badawy, M. T., Abou-Zekry, S. S., Heiba, H. H., Saadeldin, M. K., Abdellatif, A."Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration - an animal study". International Journal of Functional Nutrition 1.1 (2021): 2.
Chicago
Baset, M. E., Ali, T. I., Elshamy, H., El Sadek, A. M., Sami, D. G., Badawy, M. T., Abou-Zekry, S. S., Heiba, H. H., Saadeldin, M. K., Abdellatif, A."Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration - an animal study". International Journal of Functional Nutrition 1, no. 1 (2021): 2. https://doi.org/10.3892/ijfn.2020.2